Incyclix Bio
Incyclix Bio, LLC is a next-generation cell cycle control company, advancing precision treatments that target the aberrant proliferation driving many cancers. The company’s lead compound is a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor nearing clinical stage. Incyclix Bio is a scientific leader in understanding cyclin-dependent kinases (CDKs) and their role in the cell cycle as attractive therapeutic targets across many tumor types, including ovarian, breast and lung cancers. Headquartered in Research Triangle Park, NC, Incyclix Bio is founded by pioneers in CDK inhibitor discovery, research and development.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
11
organic / mo
Sign up free to see all 9 verified contacts at Incyclix Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- KM
Karenann Makhuli
Vice President Clinical Operations · Operations
EmailPhone - AT
Alec Trub
Research Scientist · Science
EmailPhone - JS
Jay Strum
Chief Scientific Officer · Science
EmailPhone - JE
John E. Bisi
Co-founder, Senior Vice President · Other
EmailPhone - PR
Patrick Roberts
Chief Executive Officer and Co-founder · Other
EmailPhone
Showing 5 of 9 verified contacts
Top roles at Incyclix Bio
5 distinct titles indexed · top 5 shown.
- 1chief executive officer and co-founder
- 1chief scientific officer
- 1co-founder, senior vice president
- 1research scientist
- 1vice president clinical operations
Sign up to unlock all 9 contacts at Incyclix Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Incyclix Bio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.